LICENSE AND COLLABORATION AGREEMENT among F-STAR GAMMA LIMITED, F-STAR BIOTECHNOLOGISCHE FORSCHUNGS-UND ENTWICKLUNGSGES.M.B.H, F-STAR BIOTECHNOLOGY LIMITED, and DENALI THERAPEUTICS INC. Dated as of 24 August 2016License and Collaboration Agreement • September 30th, 2020 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • England
THIS LICENSE AND COLLABORATION AGREEMENT is made and entered into effective as of 24 August 2016 (the “Effective Date”) by and between
ContractSpring Bank Pharmaceuticals, Inc. • September 30th, 2020 • Pharmaceutical preparations • England
[Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit have been omitted by means of marking such portions with asterisks as the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.]
LICENSE AND COLLABORATION AGREEMENT between F-STAR DELTA LIMITED, F-STAR BETA LIMITED, F-STAR BIOTECHNOLOGY LIMITED, F-STAR BIOTECHNOLOGISCHE FORSCHUNGS-UND ENTWICKLUNGSGES.M.B.H AND ARES TRADING S.A. Dated as of 13 May 2019License and Collaboration Agreement • September 30th, 2020 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • England and Wales
(each of Delta, Beta, F-star, F-star GmbH and Ares being a “Party” and together the “Parties”; and each of Delta, Beta, F-star and F-star GmbH being an “F-star Party” and together the “F-star Parties”).
SPRING BANK PHARMACEUTICALS, INC. RETENTION AND BONUS AWARD AGREEMENTRetention and Bonus Award Agreement • September 30th, 2020 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This Retention and Bonus Award Agreement (this “Agreement”) is made and entered into on September 9, 2020 (the “Effective Date”), between Spring Bank Pharmaceuticals, Inc. (the “Company”) and Lori Firmani (“Employee”).
GAMMA SUPPORT SERVICES AGREEMENT among F-STAR BIOTECHNOLOGY LIMITED, and F-STAR GAMMA LIMITED Dated as of 24 August 2016License Agreement • September 30th, 2020 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • England
THIS AMENDED AND RESTATED LICENSE AGREEMENT is made and entered into effective as of 24 August 2016 (the “Effective Date”) by and between
SPRING BANK PHARMACEUTICALS, INC. RETENTION AND BONUS AWARD AGREEMENTRetention and Bonus Award Agreement • September 30th, 2020 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This Retention and Bonus Award Agreement (this “Agreement”) is made and entered into on September 9, 2020 (the “Effective Date”), between Spring Bank Pharmaceuticals, Inc. (the “Company”) and Kris Iyer (“Employee”).
DENALI THERAPEUTICS INC. (1) THE SELLERS (2) and SHAREHOLDER REPRESENTATIVE SERVICES LLC (as the Sellers’ Representative) (3) SHARE PURCHASE AGREEMENT relating to the entire issued share capital of F-STAR GAMMA LIMITED COOLEY (UK) LLP, DASHWOOD, 69...Share Purchase Agreement • September 30th, 2020 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • England
SPRING BANK PHARMACEUTICALS, INC. RETENTION AND BONUS AWARD AGREEMENTRetention and Bonus Award Agreement • September 30th, 2020 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This Retention and Bonus Award Agreement (this “Agreement”) is made and entered into on September 9, 2020 (the “Effective Date”), between Spring Bank Pharmaceuticals, Inc. (the “Company”) and Garrett Winslow (“Employee”).
ContractAgreement • September 30th, 2020 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • England
[Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit have been omitted by means of marking such portions with asterisks as the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.]
